Moderna COVID Vaccine Antibody Response Edges Out Pfizer

Published on April 18, 2022

A new study suggests that Moderna’s COVID-19 vaccine may have a slight advantage over the Pfizer shot. Imagine you’re at a pizza party and you have a choice between two slices of pizza. Both slices are delicious, but one slice has just a little extra cheese which makes it even tastier. Well, in this study, researchers compared the antibody levels in people who received either the two-dose Pfizer vaccine or the two-dose Moderna vaccine. After tracking these antibody levels for 10 months, they found that the Moderna vaccine provoked a slightly stronger response. It’s like the Moderna slice had that extra cheese, giving it an edge over the Pfizer slice. This means that more people who received the Moderna vaccine may have higher antibody levels, providing them with potentially better protection against COVID-19. Now, these findings give us important information and can help guide our vaccination strategies going forward. To learn more about this research, check out the full article!

Moderna’s COVID-19 vaccine may have some slight advantages over the Pfizer shot, new research suggests. For the study, researchers tracked antibody levels in 234 people for 10 months after they received either the two-dose Pfizer (114 people) or Moderna (114 people) mRNA…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>